Clinical Trial Update: Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated whether N-acetylcysteine could protect against oxaliplatin-induced neuropathy in patients with colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Tanta University | Conditions: Colorectal Cancer | NA | Status: COMPLETED